Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism

Open access

Abstract

Butyrate (BT) is a ubiquitous short-chain fatty acid (SCFA) principally derived from the enteric microbiome. BT positively modulates mitochondrial function, including enhancing oxidative phosphorylation and beta-oxidation and has been proposed as a neuroprotectant. BT and other SCFAs have also been associated with autism spectrum disorders (ASD), a condition associated with mitochondrial dysfunction. We have developed a lymphoblastoid cell line (LCL) model of ASD, with a subset of LCLs demonstrating mitochondrial dysfunction (AD-A) and another subset of LCLs demonstrating normal mitochondrial function (AD-N). Given the positive modulation of BT on mitochondrial function, we hypothesized that BT would have a preferential positive effect on AD-A LCLs. To this end, we measured mitochondrial function in ASD and age-matched control (CNT) LCLs, all derived from boys, following 24 and 48 h exposure to BT (0, 0.1, 0.5, and 1 mM) both with and without an in vitro increase in reactive oxygen species (ROS). We also examined the expression of key genes involved in cellular and mitochondrial response to stress. In CNT LCLs, respiratory parameters linked to adenosine triphosphate (ATP) production were attenuated by 1 mM BT. In contrast, BT significantly increased respiratory parameters linked to ATP production in AD-A LCLs but not in AD-N LCLs. In the context of ROS exposure, BT increased respiratory parameters linked to ATP production for all groups. BT was found to modulate individual LCL mitochondrial respiration to a common set-point, with this set-point slightly higher for the AD-A LCLs as compared to the other groups. The highest concentration of BT (1 mM) increased the expression of genes involved in mitochondrial fission (PINK1, DRP1, FIS1) and physiological stress (UCP2, mTOR, HIF1α, PGC1α) as well as genes thought to be linked to cognition and behavior (CREB1, CamKinase II). These data show that the enteric microbiome-derived SCFA BT modulates mitochondrial activity, with this modulation dependent on concentration, microenvironment redox state, and the underlying mitochondrial function of the cell. In general, these data suggest that BT can enhance mitochondrial function in the context of physiological stress and/or mitochondrial dysfunction, and may be an important metabolite that can help rescue energy metabolism during disease states. Thus, insight into this metabolic modulator may have wide applications for both health and disease since BT has been implicated in a wide variety of conditions including ASD. However, future clinical studies in humans are needed to help define the practical implications of these physiological findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-017-0089-z

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Seahorse assay and experimental timeline. (a) Oxygen consumption rate (OCR) is measured to determine the mitochondrial activity. Three OCRs are measured over an 18-min period to determine the mitochondrial activity. Inhibitors are added to determine several parameters of mitochondrial activity. Basal respiration is initially determined as the difference between baseline OCR and non-mitochondrial OCR. Oligomycin, which is a complex V inhibitor, is added to determine the portion of basal respiration which is ATP-linked respiration and proton leak respiration. Carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazon (FCCP), a protonophore, is added to collapse the inner membrane gradient, driving the mitochondria to respire at its maximal rate. This can be used to determine maximal respiratory capacity. Antimycin A and rotenone, which are inhibitors of complexes III and I, are added to stop mitochondrial respiration in order to determine the non-mitochondrial respiration. Reserve capacity is calculated as the difference between basal respiration and maximal respiratory capacity. (b) Timeline for the experiment. Lymphoblastoid cell lines (LCLs) are exposed to one of the three concentrations of butyrate or not exposed as a baseline control. Following butyrate exposure, the LCLs are exposed to DMNQ for 1 h in order to increase reactive oxygen (ROS) species or not exposed to increased ROS. The Seahorse assay is performed after these exposures
Fig. 1 Seahorse assay and experimental timeline. (a) Oxygen consumption rate (OCR) is measured to determine the mitochondrial activity. Three OCRs are measured over an 18-min period to determine the mitochondrial activity. Inhibitors are added to determine several parameters of mitochondrial activity. Basal respiration is initially determined as the difference between baseline OCR and non-mitochondrial OCR. Oligomycin, which is a complex V inhibitor, is added to determine the portion of basal respiration which is ATP-linked respiration and proton leak respiration. Carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazon (FCCP), a protonophore, is added to collapse the inner membrane gradient, driving the mitochondria to respire at its maximal rate. This can be used to determine maximal respiratory capacity. Antimycin A and rotenone, which are inhibitors of complexes III and I, are added to stop mitochondrial respiration in order to determine the non-mitochondrial respiration. Reserve capacity is calculated as the difference between basal respiration and maximal respiratory capacity. (b) Timeline for the experiment. Lymphoblastoid cell lines (LCLs) are exposed to one of the three concentrations of butyrate or not exposed as a baseline control. Following butyrate exposure, the LCLs are exposed to DMNQ for 1 h in order to increase reactive oxygen (ROS) species or not exposed to increased ROS. The Seahorse assay is performed after these exposuresCC BY · PubMed Central
Fig. 2 Butyrate (BT) modulates mitochondrial function in control lymphoblastoid cell lines in a concentration-dependent manner. Lymphoblastoid cell lines were exposed for either 24 h or 48 h in BT and the mitochondrial function was measured. Average changes in the mitochondrial function across the two exposure times is shown since there was no difference across the two exposure times. ATP-linked respiration (a), maximal respiratory capacity (c), reserve capacity (d), glycolytic rate (e), and glycolytic Reserve (f) were reduced at 1.0 mM BT relative to no BT exposure. Glycolytic metabolism was reduced to a greater extent as compared to oxidative metabolism, resulting in an increase in the basal oxidative (OCR) to glycolytic (ECAR) ratio (g) and the maximal oxidative (OCR) to glycolytic (ECAR) capacity ratio (h) for 1.0 mM BT as compared to no butyrate exposure. Since there was few difference in these relationships across BT exposure times, the average of the two exposure times is presented. Significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 2 Butyrate (BT) modulates mitochondrial function in control lymphoblastoid cell lines in a concentration-dependent manner. Lymphoblastoid cell lines were exposed for either 24 h or 48 h in BT and the mitochondrial function was measured. Average changes in the mitochondrial function across the two exposure times is shown since there was no difference across the two exposure times. ATP-linked respiration (a), maximal respiratory capacity (c), reserve capacity (d), glycolytic rate (e), and glycolytic Reserve (f) were reduced at 1.0 mM BT relative to no BT exposure. Glycolytic metabolism was reduced to a greater extent as compared to oxidative metabolism, resulting in an increase in the basal oxidative (OCR) to glycolytic (ECAR) ratio (g) and the maximal oxidative (OCR) to glycolytic (ECAR) capacity ratio (h) for 1.0 mM BT as compared to no butyrate exposure. Since there was few difference in these relationships across BT exposure times, the average of the two exposure times is presented. Significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001CC BY · PubMed Central
Fig. 3 Oxidative stress overall reduced the parameters of ATP production and increases the parameters of reactive oxygen species control in mitochondrial function in control lymphoblastoid cell lines. This resulted in a decrease in reserve capacity (d) with butyrate (BT) exposure. Oxidative stress also reduced the glycolytic rate (e) but increased the glycolytic reserve capacity (f). Overall oxidative stress shifts the metabolism toward a more oxidative state (g) but decreased maximum oxidative metabolism (h). However, relative to baseline changes in mitochondrial function without oxidative stress, 1.0 mM BT did not have the same detrimental effect on (a) ATP-linked respiration, (c) maximal respiratory capacity, and reserve capacity (d), suggesting that BT may have a protective effect on mitochondria when they are under physiological stress. Lymphoblastoid cell lines are pretreated with 10 µM of 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) for 1 h to increase the intracellular reactive oxygen species before the mitochondrial assay after BT has been washed from the cell culture. The bars adjacent to the data lines represent the overall significant difference. Statistical significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 3 Oxidative stress overall reduced the parameters of ATP production and increases the parameters of reactive oxygen species control in mitochondrial function in control lymphoblastoid cell lines. This resulted in a decrease in reserve capacity (d) with butyrate (BT) exposure. Oxidative stress also reduced the glycolytic rate (e) but increased the glycolytic reserve capacity (f). Overall oxidative stress shifts the metabolism toward a more oxidative state (g) but decreased maximum oxidative metabolism (h). However, relative to baseline changes in mitochondrial function without oxidative stress, 1.0 mM BT did not have the same detrimental effect on (a) ATP-linked respiration, (c) maximal respiratory capacity, and reserve capacity (d), suggesting that BT may have a protective effect on mitochondria when they are under physiological stress. Lymphoblastoid cell lines are pretreated with 10 µM of 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) for 1 h to increase the intracellular reactive oxygen species before the mitochondrial assay after BT has been washed from the cell culture. The bars adjacent to the data lines represent the overall significant difference. Statistical significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001CC BY · PubMed Central
Fig. 4 Butyrate (BT) enhances the mitochondrial function in autistic lymphoblastoid cell lines (LCLs) with atypical mitochondrial function (AD-A) over and above the effect it has on control LCLs in a concentration- and exposure time-dependent manner. ATP-linked respiration (a), maximal respiratory capacity (c), and reserve capacity (d) were enhanced over and above the control values for the AD-A LCLs with BT exposure, particularly for 0.1 and 1.0 mM BT concentrations. The bars adjacent to the data lines represent overall significant differences. The color of the stars and bars represents the specific comparisons. Green represents the difference between AD-A and control LCLs. Orange represents the difference between AD-N and control LCLs. Blue represents the difference between the AD-N and AD-A LCLs. Statistical significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 4 Butyrate (BT) enhances the mitochondrial function in autistic lymphoblastoid cell lines (LCLs) with atypical mitochondrial function (AD-A) over and above the effect it has on control LCLs in a concentration- and exposure time-dependent manner. ATP-linked respiration (a), maximal respiratory capacity (c), and reserve capacity (d) were enhanced over and above the control values for the AD-A LCLs with BT exposure, particularly for 0.1 and 1.0 mM BT concentrations. The bars adjacent to the data lines represent overall significant differences. The color of the stars and bars represents the specific comparisons. Green represents the difference between AD-A and control LCLs. Orange represents the difference between AD-N and control LCLs. Blue represents the difference between the AD-N and AD-A LCLs. Statistical significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001CC BY · PubMed Central
Fig. 5 Butyrate (BT) enhances the parameters of ATP production even when the ASD lymphoblastoid cell lines (LCLs) are subjected to increased oxidative stress, especially for the ASD LCLs with atypical mitochondrial function (AD-A). LCLs are pretreated with 10 µM of 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) for 1 h to increase the intracellular reactive oxygen species before the mitochondrial assay after BT has been washed from the cell culture. BT significantly increased the maximal respiratory capacity (c) above the control values in a manner similar to the increase seen without DMNQ exposure. This positively affected the reserve capacity (d). The color of the stars and bars represents the specific comparisons. Green represents the difference between AD-A and control LCLs. Orange represents the difference between AD-N and control LCLs. Blue represents the difference between the AD-N and AD-A LCLs. Statistical significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 5 Butyrate (BT) enhances the parameters of ATP production even when the ASD lymphoblastoid cell lines (LCLs) are subjected to increased oxidative stress, especially for the ASD LCLs with atypical mitochondrial function (AD-A). LCLs are pretreated with 10 µM of 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) for 1 h to increase the intracellular reactive oxygen species before the mitochondrial assay after BT has been washed from the cell culture. BT significantly increased the maximal respiratory capacity (c) above the control values in a manner similar to the increase seen without DMNQ exposure. This positively affected the reserve capacity (d). The color of the stars and bars represents the specific comparisons. Green represents the difference between AD-A and control LCLs. Orange represents the difference between AD-N and control LCLs. Blue represents the difference between the AD-N and AD-A LCLs. Statistical significance levels: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001CC BY · PubMed Central
Fig. 6 The effect of butyrate on the individual variation in mitochondrial function for the three types of lymphoblastoid cell lines
Fig. 6 The effect of butyrate on the individual variation in mitochondrial function for the three types of lymphoblastoid cell linesCC BY · PubMed Central
Fig. 7 Change in expression of key genes involved in the response to physiological stress as a result of butyrate exposure
Fig. 7 Change in expression of key genes involved in the response to physiological stress as a result of butyrate exposureCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 112 references

Research works printed but not linked: 1

  1. Frye, R. E. Biomarkers of Abnormal Energy Metabolism in Children with Autism Spectrum Disorder. North Am. J. Med. Sci. 5, 141–147 (2012). · DOI

Cited by

See all 245

Metadata

Authors
Rose, S., Bennuri, S. C., Davis, J. E., Wynne, R., Slattery, J. C., Tippett, M., Delhey, L., Melnyk, S., Kahler, S. G., MacFabe, D. F., & Frye, R. E.
Affiliations
  • Arkansas Children's Research Institute (US)
  • Alberta Children's Hospital Research Institute (CA)
  • Barrow Neurological Institute (US)
Corresponding author
Frye, Richard E.
Venue
Translational Psychiatry
Published
2018-02-02
Volume
8
Issue
1
Pages
42-42
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2802398839
Cited by
226
References
112
Citations by year
2026: 27 · 2025: 24 · 2024: 31 · 2023: 20 · 2022: 40 · 2021: 26 · 2020: 29 · 2019: 18 · 2018: 11
FWCI
7.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
butyrate, short-chain fatty acids, autism spectrum disorder, mitochondrial dysfunction, oxidative stress, reactive oxygen species, lymphoblastoid cell lines, mitochondrial respiration, ATP production, PINK1, Drp1, Fis1, PGC-1α, mTOR, HIF-1α, UCP2, CREB1, CaMKII
MeSH terms
Autism Spectrum Disorder, Gastrointestinal Microbiome, Butyrates, Cell Line, Child, Humans, Lymphocytes, Male, Mitochondria, Reactive Oxygen Species, Oxidative Stress, Mitochondrial Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. https://app.cochat.ai/papers/10.1038/s41398-017-0089-z
The paper
Rose, S., Bennuri, S. C., Davis, J. E., Wynne, R., Slattery, J. C., Tippett, M., Delhey, L., Melnyk, S., Kahler, S. G., MacFabe, D. F., & Frye, R. E. (2018). Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Translational Psychiatry. https://doi.org/10.1038/s41398-017-0089-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.